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Ventilatory control undergoes profound changes on ascent to high altitude. We hypothesized
that the fall in citric acid cough threshold seen on ascent to altitude is mediated by changes
in the central control of cough and would parallel changes in central ventilatory control as-
sessed by the hypercapnic ventilatory response (HCVR). Twenty-five healthy volunteers under-
went measurements of HCVR and citric acid sensitivity at sea level and during a 9 day sojourn
at 5200 m. None of the subjects had any evidence of respiratory infection. Citric acid cough
threshold fell significantly on ascent to 5200 m. The slope, S, of the HCVR increased signifi-
cantly on ascent to 5200 m and during the stay at altitude. There was no correlation between
citric acid sensitivity and HCVR. We conclude that the change in citric acid cough threshold
seen on exposure to hypobaric hypoxia is unlikely to be mediated by changes in the central
control of cough. Sensitivity to citric acid may be due to early subclinical pulmonary edema
stimulating airway sensory nerve endings.
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High-altitude cough 1183Introduction was approved by the Lothian Research Ethics Committee.Climbers and travelers to high altitude have long reported
a troublesome paroxysmal cough severe enough to cause rib
fractures.1e3 In the first systematic study of high-altitude
cough an increase in nocturnal cough frequency and cough
receptor sensitivity to citric acid were shown in a group of
subjects ascending to 5300 m in the Nepalese Himalaya,
with a massive increase in nocturnal cough frequency in the
3 climbers in whom recordings were possible at 7000 m.4
High-altitude cough was traditionally attributed to the
inspiration of cold, dry air. However, observations and
experiments in two long-duration hypobaric chamber
studies mimicking ascents of Mount Everest showed that
cough still occurs despite controlled temperature and
humidity.5,6 During the second of these chamber studies
(Operation Everest-COMEX), nocturnal cough frequency
increased and citric acid cough threshold fell despite careful
control of temperature and humidity in the chamber.6
Because the cause of high-altitude cough remains
unclear, methods to treat or prevent this important
symptom may be difficult to develop. Suggested causes
have been discussed fully in a recent review.7 Respiratory
control undergoes profound changes with exposure to high
altitude, and several lines of evidence suggest that changes
in respiratory control also affect the tendency to cough.8 A
number of factors which suppress cough also suppress
ventilation, such as sleep and centrally acting anti-tussive
agents.9,10 Banner demonstrated a lower hypercapnic
ventilatory response (HCVR) in a subgroup of healthy
volunteers at sea level who did not cough in response to
inhaled hypotonic saline and suggested that cough sensi-
tivity and HCVR might be mediated by a common central
mechanism.11 Little is known about any direct relationship
between HCVR and cough generation, but in anesthetized
humans hypercapnia was demonstrated to inhibit tracheal
cough.12 Further possible evidence for a link between
ventilatory control and cough at altitude came from a study
at 5300 m in which a post-hoc analysis of data demon-
strated a relationship between citric acid cough threshold
and the ventilatory response to early inspired pulses of
carbon dioxide.13
We hypothesized that high-altitude cough could be
caused by central alterations in respiratory control. We
predicted that if the link between HCVR and cough was
strong, there would be a correlation between susceptibility
to cough at altitude, as measured by the citric acid cough
challenge, and either sea level HCVR or the change in HCVR
between sea level and altitude.
Methods
Subjects
25 healthy subjects (15 male, 10 female, age range 18e54
years) underwent baseline testing at sea level in the United
Kingdom before flying to La Paz, Bolivia (altitude 3630 m).
Subjects remained in La Paz for 4 days to acclimatize
before ascending by road over 90 min to the Chacaltaya
Laboratory at 5200 m where they stayed for 9 days. All
subjects gave written informed consent and the projectAll subjects were non-smokers and had no history of
respiratory disease; none were taking regular medication
before or during the study.
Citric acid cough threshold
After a control solution of 0.9% saline, subjects inhaled
solutions of citric acid via an ultrasonic nebulizer (Sonix
2000, Clement Clarke International, Harlow, UK) during
a slow vital capacity inspiration over 5 s as previously
described.4 Ten solutions of citric acid doubling in
concentration from 0.31 to 160 g l1 were used. To avoid
a learning effect the concentrations were administered in
random order, although the stronger concentrations were
not given early in the test to avoid airway irritation.4 Each
solution was inhaled 3 times and the cough threshold was
defined as the lowest concentration which provoked
a cough providing that a cough was also provoked at the
next concentration. To avoid diurnal variations in cough
sensitivity to citric acid14,15 all tests were performed
between 14:00 and 18:00 h. Citric acid cough challenges
were performed at sea level (SL) prior to departure and on
days 1, 3, 5 and 9 at 5200 m (HA1, HA3, HA5 and HA9
respectively). The method differs from recently-published
European Respiratory Society guidelines16 as the guidelines
were published after this study was completed.
Before and after each citric acid test peak expiratory
flow was recorded using a Mini-Wright peak flow meter
(Airmed, Clement Clarke International, UK). Although the
measurements made with this variable-orifice flow meter
are profoundly altered by the fall in air density with
increasing altitude17 it was only being used to exclude
bronchospasm after inhalation of citric acid, and so being
light and portable lent itself ideally to use at high altitude.
Hypercapnic ventilatory response
HCVR was measured using the rebreathing method of
Read.18 Subjects refrained from alcohol and caffeine for
12 h prior to each measurement. After breathing room air
for 5 min breathing was switched to the bag-in-box appa-
ratus using a 3-way valve. The 6 l bag contained 95% O2
and 5% CO2 at sea level, while at altitude the CO2
concentration was adjusted to around 7.5% to exceed
slightly the end tidal partial pressure of CO2 ðPE0CO2 Þ.
Rebreathing continued for 4 min or until the CO2 concen-
tration had risen by 4%. The test was stopped if the
subject experienced discomfort.
At sea level ventilation was measured using flow data
from a F1000L pneumotachograph (GM Instruments, Kil-
winning, UK) and at altitude with a turbine spirometer
(VmaxST, Sensormedics, Yorba Linda, CA, USA). End tidal
CO2 was measured using a sidestream, infra-red analyser
(Datex Normocap CD200 or Datex Oxicap, Datex-Ohmeda,
Hatfield, UK at sea level, and Vmax ST at 5200 m). The
analogue flow and CO2 signals were digitized using an
analogueedigital converter (instruNet iNET-100B, Amplicon
Liveline Ltd, Brighton, UK) and displayed using software
supplied with the converter on a laptop PC. HCVR was
measured at SL and days 2 and 8 at 5200 m (HA2 and HA8
respectively).
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Figure 1 Change in citric acid cough threshold (g l1) with
time at 5200 m for male and female subjects. Error bars
represent SE. SL: Sea level. HA1, HA3, HA5, HA9: days 1, 3, 5
and 9 respectively at 5200 m. *p< 0.05 for pooled mean cf sea
level control.
1184 A.A.R. Thompson et al.Hypercapnic ventilatory response data were plotted
using Sigma Plot v8.0 (SPSS Inc. Chicago, Illinois, USA) and
the slope of the linear section of the curve (S ) calculated
using least squares linear regression.
Acute mountain sickness
Acute mountain sickness (AMS) was assessed each day using
the Lake Louise scoring system.19
Completeness of the data
Three male and 2 female subjects withdrew from the study
at 5200 m because of severe AMS. One male subject
persistently hyperventilated during HCVR testing at 5200 m.
These subjects have been excluded from all analyses.
Hypercapnic ventilatory response was only measured in
male subjects as menstrual cycle variability in ventilatory
control complicates the interpretation of results in
females.20
Statistical analysis
Data were analyzed for normality using QeQ plots and the
KolmogoroveSmirnov Test. Serial measures were tested for
statistical significance using one way analysis of variance
(ANOVA) for repeated measures with significant post hoc
differences being analyzed using a Tukey test. HCVR was
compared with citric acid cough threshold (CACT) using
correlation plots and the Bonferroni correction for multiple
comparisons was applied. Analyses were performed using
SPSS vs. 11.5 software and Sigma Plot v8.0 (SPSS Inc. Chi-
cago, Illinois, USA).
Results
Citric acid cough threshold
Data were available for 20 subjects. Data were positively
skewed. Transformation, by taking natural logarithms,
resulted in data at each point passing the Kolmogorove
Smirnov test. Citric acid cough threshold fell from
a geometric mean value at SL of 3.7 g/dl (95% CIs 23.2e
64.3) to 2.5 g/dl (95% CIs 1.6e20.0) on HA1 (geometric
mean difference 3.1, 95% CIs 1.4e6.9, pZ 0.002). It
remained significantly reduced compared to SL at HA3
(2.8 g/dl, 95% CIs 11.1e23.8, geometric mean difference
2.4, 95% CIs 1.08e5.23, pZ 0.026) and HA9 (2.7 g/dl, 95%
CIs 9.5e24.1, geometric mean difference 2.55, 95% CIs
1.2e5.6, pZ 0.014). The trend towards a reduction at HA5
(3.3 g/dl, 95% CIs 16.0e43.4) compared to SL did not meet
statistical significance (geometric mean difference 1.46,
95% CIs 0.67e3.22, pZ 0.57). We found no difference
between male and female subjects. These data are shown
in Fig. 1.
Hypercapnic ventilatory response
Data were available from 12 subjects and were normally
distributed. The slope, S, increased from a mean value of14.52 l min1 kPa CO2
1 (95% CIs 12.34e16.70) at SL, to
32.11 l min1 kPa CO2
1 (95% CIs 22.73e41.49) at HA2
(difference between means 17.59, p< 0.001) and
35.64 l min1 kPa1 (95% CIs 27.93e43.34) at HA8 (difference
between means 21.20, p< 0.001). There was no significant
difference between HA2 and HA8.
The PE0CO2
for a ventilation of 15 l min1 has been
calculated from the regression equation for each subject,
this being more meaningful than the intercept with the
ordinate, when PE0CO2
Z0. The PE0CO2
at a ventilation of
15 l min1 decreased from a mean value of 7.45 kPa (95%
CIs 6.97e7.93) at SL, to 5.07 kPa (95% CIs 4.91e5.23) at
HA2 (difference between means 2.71, p< 0.001) and
4.75 kPa (95% CIs 4.59e4.92) at HA8 (difference between
means 2.39, p< 0.001). There was no significant difference
between HA2 and HA8.
An example of a HCVR plot from one subject is shown in
Fig. 2 and HCVR data from individual subjects are summa-
rized in Table 1.
Correlation between CACT and HCVR
There was no significant correlation between the SL slope
of HCVR and the natural logarithm of CACT. There was
a significant but weak negative correlation between the
slope of HCVR and the natural log of CACT when data were
pooled from all altitudes (rZ 0.382, pZ 0.028). This is
illustrated in Fig. 3. There was a significant positive
correlation between the SL slope of HCVR and the change in
the natural log of CACT from SL to HA1 (rZ 0.678,
pZ 0.022). This is shown in Fig. 4. There was no difference
in HCVR between any groups of high and low CACT, irre-
spective of the arbitrary division used.
There was no correlation between AMS score or SpO2 and
CACT.
Discussion
We have demonstrated a decrease in citric acid cough
threshold (CACT) on ascent to 5200 m which remained
decreased after 9 days at altitude. This fall in CACT with
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Figure 2 Sample HCVR plot from subject 11.
High-altitude cough 1185decreasing barometric pressure is consistent with previous
findings at a similar altitude4 and in a hypobaric chamber
study to the barometric equivalent of the summit of Mount
Everest.6 We have also demonstrated an increase in the
hypercapnic ventilatory response (HCVR) on ascent to
5200 m which was sustained throughout the stay at 5200 m,
consistent with previous reports.21 We did not demonstrateTable 1 Summary of hypercapnic ventilatory response (HCVR)
Subject Sea Level HA2
S CO2 V15 r S
1 16.93 6.04 0.944* 42.11
3 17.09 6.83 0.958* 56.98
5 12.08 8.03 0.866* 20.45
7 10.98 8.37 0.837* 16.56
11 17.99 8.08 0.989* 25.91
13 15.08 7.16 0.938* 29.80
14 16.09 7.74 0.925* 35.00
15 9.89 8.42 0.932* 13.69
16 15.80 7.28 0.956* 33.11
21 7.87 6.97 0.946* 16.46
24 18.11 6.63 0.948* 57.19
25 16.32 7.90 0.909* 38.09
Mean 14.52 7.45 32.11y
U 95% CI 16.7 7.93 41.49
L 95% CI 12.34 6.97 22.73
S: slope of HCVR curve (l min1 kPa CO2
1).
CO2 V15: End tidal CO2 (kPa) at ventilation of 15 l min
1.
r: correlation coefficient for linear regression model.
U 95% CI and L 95% CI: upper and lower 95% confidence intervals of t
*p< 0.001. yp< 0.001 cf sea level control.a convincing relationship between CACT and HCVR or
between the changes in CACT and HCVR with ascent to
altitude.
We chose to investigate the relationship between CACT
and HCVR because of previous work which showed that
subjects who did not cough in response to inhaled hypo-
tonic saline at sea level had a lower HCVR compared with
those who did cough, suggesting that cough sensitivity and
HCVR might be mediated by a common mechanism, and
because HCVR undergoes profound changes on ascent to
and with acclimatization to altitude.8 The central control
of cough is complex and poorly understood.22e24 We
hypothesized that a subject’s underlying central ventilatory
control as represented by HCVR, or the change in that
ventilatory control on ascent to altitude, could influence or
parallel their susceptibility to cough at altitude. Although
the hypoxic ventilatory response (HVR), which is mediated
via the peripheral chemoreceptors in the carotid bodies
also increases with acclimatization to altitude, it is unclear
whether the increased sensitivity of HVR is due to changes
in peripheral chemoreceptor sensitivity or changes in the
central integrating mechanism.25 One reported post-hoc
analysis, which must be interpreted with caution, also
suggested a relationship between CACT and the ventilatory
response to early inspired pulses of carbon dioxide.13
The only previous report of a relationship between HCVR
and cough sensitivity used hypotonic saline as a challenge.
We chose to use citric acid as our cough challenge to
maintain consistency with previous studies at altitude,4,6
because hypotonic saline can potentially cause broncho-
constriction26 and because the hypotonic saline challenge is
difficult to standardize as it is very dependent upon nebu-
lizer output.16 Changes in nebulizer output secondary to
reduced barometric pressure are a possible false cause of
a change in citric acid cough threshold on ascent todata in 12 subjects.
HA8
CO2 V15 r S CO2 V15 r
5.07 0.952* 38.82 4.84 0.984*
5.04 0.970* 39.61 4.64 0.969*
4.74 0.958* 28.20 4.71 0.973*
5.48 0.888* 27.89 5.05 0.837*
4.86 0.923* 41.40 4.52 0.990*
5.23 0.965* 55.20 4.52 0.938*
5.40 0.938* 31.63 4.68 0.951*
5.24 0.934* 14.92 4.99 0.908*
4.72 0.897* 30.89 4.67 0.958*
5.23 0.970* 20.87 4.60 0.968*
5.03 0.968* 53.57 5.32 0.979*
4.80 0.935* 44.62 4.42 0.992*
5.07y 35.64y 4.75y
5.23 43.34 4.92
4.91 27.93 4.59
he mean, respectively.
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Figure 3 Linear regression line of the natural logarithm of
the citric acid cough threshold (ln CACT) plotted against the
slope (S ) of the hypercapnic ventilatory response (HCVR) for
pooled data from all altitudes (SL: sea level; HA1, HA2, HA8
and HA9 the first, second, eighth and ninth days at 5200 m
respectively). The regression equation describing the line is
ln CACTZ 3.704 (0.0275 S ); correlation coefficient
rZ 0.382, pZ 0.028. See Discussion for interpretation.
1186 A.A.R. Thompson et al.altitude. Barry assessed the output of three types of
nebulizers in a hypobaric chamber at sea level and altitudes
equivalent to 4200 and 5300 m.27 While the output from the
ultrasonic device used in this study fell by only 23% at
4200 m and 13% at 5300 m, the output from both
a conventional jet nebulizer and a breath enhanced nebu-
lizer fell by over 50% at the simulated altitudes compared
with sea level. In a further study serum salbutamol levels
were measured in human subjects following ultrasonicSea Level HCVR slope (S) / litres.min
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Figure 4 Linear regression line of the change in the natural
logarithm of the citric acid cough threshold (ln CACT) between
sea level (SL) and the first day at 5200 m (HA1) plotted against
the sea level slope (S ) of the hypercapnic ventilatory response
(HCVR). The regression equation describing the line is: change
in ln CACTZ4.184þ (0.211 S ); correlation coefficient
rZ 0.678, pZ 0.022. See Discussion for interpretation.nebulizer administration of salbutamol at sea level and
a simulated altitude of 5000 m in a hypobaric chamber.27
There was no difference in serum salbutamol levels
between these altitudes. These findings argue against
changes in nebulizer output producing a false change in
citric acid cough threshold on ascent to altitude.
There was a significant correlation between the sea
level slope, S, of HCVR and the change in CACT from sea
level to the first day at 5200 m (Fig. 4). This would suggest
that those subjects with a low initial HCVR had minimal or
no change, or even an increase, in CACT on ascent to
5200 m, while those with a brisk initial HCVR had the more
usual fall in CACT indicating increased sensitivity to citric
acid on ascent to altitude. However the relationship is
weak and significantly skewed by one outlying data point
(SZ 8 l min1 kPa CO2
1). Removing this outlier renders the
correlation insignificant and we believe it to be spurious.
There was a significant, but weak (rZ 0.382), negative
correlation between the slope of HCVR and the natural log
of CACT when data were pooled from all altitudes sug-
gesting that those subjects with the lowest HCVR were the
most resistant to citric acid, while those with the highest
HCVR and who had the lowest cough threshold were most
sensitive to citric acid (Fig. 3). While this relationship
appears to be intuitively correct if the central control of
cough and respiration are linked, it depends primarily on
the low values of HCVR which were measured at sea level.
As such it is equally explicable as a simple altitude effect
on HCVR.
Our findings substantiate the work of Banner found no
correlation between HCVR and cough threshold in those
subjects who did cough in response to hypotonic saline.11
TakingBanner’swork togetherwith thepresent study it seems
unlikely that the changes seen in CACT on ascent to altitude
are related to respiratory control as reflected by HCVR.
A weakness of the study design is the lack of a control
group unexposed to hypobaric hypoxia and challenged at
sea level with successive citric acid exposures. A short-term
tachyphylaxis occurs when tests are performed within hours
of each other.28 Apart from this, we think it is unlikely that
repeated exposure to citric acid will have a longer lasting
effect on cough receptors. Cough threshold tests on 4
normal and 8 asthmatic subjects, repeated on 4 occasions
within 10 days showed that baseline cough threshold did
not vary by more than two dosage increments in any
subject.29 We believe the reproducibility of the CACT is
robust enough to allow valid comparison between our sea
level and altitude data, despite the time interval between
initial testing and testing at altitude. Tests conducted 1 day
or 2 weeks apart are reproducible within one doubling of
the citric acid concentration.30,31
Citric acid stimulates airway sensory nerve receptors
which constitute a heterogeneous group activated by
a number of stimuli including gaseous or aerosolized irri-
tants; inflammatory and immunological mediators such as
bradykinin; edema and atelectasis.32 It has recently been
suggested that the term altitude-related coughmay cover at
least two conditions: a cough which can occur at lower
altitudes, which is related to exercise and possibly trauma or
infection of the respiratory tract and a cough which is only
a clinical problem at higher altitudes.7 None of the subjects
in the current study showed signs of respiratory tract
High-altitude cough 1187infection and the ascent to high altitude by vehicle did not
involve exercise, excluding the first mechanism as a cause
for the change in CACT seen in this study. If changes in the
central control of cough can be tentatively excluded, this
leaves subclinical edema stimulating pulmonary afferents as
an explanation for the changes seen in CACT in this study.
Edema stimulates both rapidly adapting receptors and C-
fibres in animal models33e35 and two mechanisms have been
shown to be capable of causing subclinical pulmonary
edema at high altitude. Hypoxic pulmonary vasoconstric-
tion increases pulmonary artery pressure. The vasocon-
striction is uneven, reducing blood flow in some areas but
leading to overperfusion of others and exposing those
capillaries to high transmural pressures.36 If pulmonary
capillary pressure is sufficiently elevated, this will result in
clinical pulmonary edema. In haemodynamic studies in
humans at 4559 m a minimum pulmonary capillary pressure
of 19 mmHg was necessary for the development of clinical
high-altitude pulmonary edema.37 However in a rabbit
model increased activity in airway rapidly adapting recep-
tors was demonstrated with increases in left atrial
pressure of as little as 5 mmHg.38 The pulmonary capillary
pressure resulting from these modest increases in left atrial
pressure is not known and although the mechanisms
elevating pulmonary capillary pressure are very different in
these two models, small degrees of hypoxic pulmonary
vasoconstriction could result in a raised pulmonary capil-
lary pressure and sensitization of rapidly adapting recep-
tors before any clinical pulmonary edema becomes evident.
As pulmonary artery pressure increases with exercise39 this
mechanism would also explain the observation that cough
at altitude can often be precipitated by exercise.
The second possible mechanism which could result in
subclinical edema sufficient to stimulate pulmonary affer-
ents is an alteration in transepithelial fluid transport. There
is increasing evidence that this mechanism, which is
necessary for the resolution of pulmonary edema,40 is
deranged in hypoxia.41e43 An etiological role for subclinical
pulmonary edema in altitude-related cough should be
investigated further by intervention studies using agents
known to lower pulmonary artery pressure or increase
transepithelial fluid clearance.
In conclusion we have failed to demonstrate
a convincing relationship between the change in CACT
which occurs on ascent to high altitude and changes in the
central control of ventilation as represented by HCVR. In
the absence of signs of respiratory tract infection this
suggests that the fall in CACT seen in this study, and in
previous studies in hypobaric hypoxia, may be due to early
subclinical pulmonary edema stimulating airway sensory
nerve endings. Further studies are required to investigate
this mechanism.
Conflict of interest
No known conflicts of interest.
Acknowledgements
The authors would like to thank Datex-Ohmeda Ltd.,
Amplicon Liveline Ltd. and Sensormedics for the loan ofequipment and technical support. We also thank all the
expedition members, especially Dr S. Patel, J. Read, Y. D.
J. Bennett and J. Balfour, who helped carry out the
research.
References
1. Steele P. Medicine on Mount Everest 1971. Lancet 1971;2:32e9.
2. Litch JA, Tuggy M. Cough induced stress fracture and
arthropathy of the ribs at extreme altitude. Int J Sports Med
1998;19:220e2.
3. Tasker J. Everest the cruel way. London: Eyre Methuen Ltd.;
1981.
4. Barry PW, Mason NP, Riordan M, et al. Cough frequency and
cough-receptor sensitivity are increased in man at altitude.
Clin Sci (Lond) 1997;93:181e6.
5. Houston CS, Sutton JR, Cymerman A, et al. Operation
Everest II: man at extreme altitude. J Appl Physiol 1987;63:
877e82.
6. Mason NP, Barry PW, Despiau G, et al. Cough frequency and
cough receptor sensitivity to citric acid challenge during
a simulated ascent to extreme altitude. Eur Respir J 1999;13:
508e13.
7. Mason NP, Barry PW. Altitude-related cough. Pulm Pharmacol
Ther 2007;20:388e95.
8. Ward MP, Milledge JS, West JB. Ventilatory response to hypoxia
and carbon dioxide. In: High altitude medicine and physiology.
London: Arnold; 2000. p. 50e64.
9. Douglas NJ. Control of breathing during sleep. Clin Sci (Lond)
1984;67:465e71.
10. Gutstein H, Akil H. Opioid analgesics. In: Brunton LL, editor.
Goodman and Gilman’s the pharmacological basis of thera-
peutics. New York: McGraw-Hill; 2006. p. 578e9.
11. Banner AS. Relationship between cough due to hypotonic
aerosol and the ventilatory response to CO2 in normal subjects.
Am Rev Respir Dis 1988;137:647e50.
12. Nishino T, Sugimori K, Hiraga K, et al. Influence of CPAP on
reflex responses to tracheal irritation in anesthetized humans.
J Appl Physiol 1989;67:954e8.
13. Barry PW, Mason NP, Nickol A, et al. Cough receptor sensitivity
and dynamic ventilatory response to carbon dioxide in man
acclimatised to high altitude [Abstract]. J Physiol 1996;497:
29e30.
14. Pounsford JC, Saunders KB. Diurnal variation and adaptation of
the cough response to citric acid in normal subjects. Thorax
1985;40:657e61.
15. Hsu JY, Stone RA, Logan-Sinclair RB, et al. Coughing frequency
in patients with persistent cough: assessment using a 24 hour
ambulatory recorder. Eur Respir J 1994;7:1246e53.
16. Morice AH, Fontana GA, Belvisi MG, et al. ERS guidelines on the
assessment of cough. Eur Respir J 2007;29:1256e76.
17. Pedersen OF, Miller MR, Sigsgaard T, et al. Portable peak flow
meters: physical characteristics, influence of temperature,
altitude, and humidity. Eur Respir J 1994;7:991e7.
18. ReadDJ. A clinicalmethod for assessing the ventilatory response
to carbon dioxide. Australas Ann Med 1967;16:20e32.
19. Roach RC, Ba¨rtsch P, Hackett PH, et al. The Lake Louise acute
mountain sickness scoring system. In: Sutton JR, Houston CS,
Coates G, editors. Hypoxia and mountain medicine. Burling-
ton, VT: Queen City Printers; 1993. p. 272e4.
20. Schoene RB, Robertson HT, Pierson DJ, et al. Respiratory drives
and exercise in menstrual cycles of athletic and nonathletic
women. J Appl Physiol 1981;50:1300e5.
21. Kellogg RH. The role of CO2 in altitude acclimatization. In:
Cunningham DJC, Lloyd BB, editors. The regulation of human
respiration. Oxford: Blackwell Scientific Publications; 1963. p.
379e94.
1188 A.A.R. Thompson et al.22. Bolser DC, Davenport PW. Functional organization of the
central cough generation mechanism. Pulm Pharmacol Ther
2002;15:221e5.
23. Bonham AC, Sekizawa S, Chen CY, et al. Plasticity of brainstem
mechanismsof cough.Respir Physiol Neurobiol 2006;152:312e9.
24. Bonham AC, Chen CY, Sekizawa S, et al. Plasticity in the
nucleus tractus solitarius and its influence on lung and airway
reflexes. J Appl Physiol 2006;101:322e7.
25. Smith C, Dempsey JA. Control of breathing at high altitude. In:
Hornbein TF, editor. High altitude, an exploration of human
adaptation. New York: Marcel Dekker; 2001. p. 139e73.
26. Eschenbacher WL, Boushey HA, Sheppard D. Alteration in
osmolarity of inhaled aerosols cause bronchoconstriction and
cough, but absence of a permeant anion causes cough alone.
Am Rev Respir Dis 1984;129:211e5.
27. Barry PW. The output of nebulisers at high altitude [abstract].
High Alt Med Biol 2000;2:114.
28. Morice AH, Higgins KS, Yeo WW. Adaptation of cough reflex
with different types of stimulation. Eur Respir J 1992;5:841e7.
29. Pounsford JC, Birch MJ, Saunders KB. Effect of bronchodilators
on the cough response to inhaled citric acid in normal and
asthmatic subjects. Thorax 1985;40:662e7.
30. Barber CM, Curran AD, Bradshaw LM, et al. Reproducibility and
validity of a Yan-style portable citric acid cough challenge.
Pulm Pharmacol Ther 2005;18:177e80.
31. Dicpinigaitis PV. Short- and long-term reproducibility of capsaicin
cough challenge testing. Pulm Pharmacol Ther 2003;16:61e5.
32. Sant’Ambrogio G, Widdicombe J. Reflexes from airway rapidly
adapting receptors. Respir Physiol 2001;125:33e45.
33. Zhang Z, Bonham AC. Lung congestion augments the responses
of cells in the rapidly adapting receptor pathway to cigarette
smoke in rabbit. J Physiol 1995;484(Pt 1):189e200.34. Roberts AM, Kaufman MP, Baker DG, et al. Reflex tracheal
contraction induced by stimulation of bronchial C-fibers in
dogs. J Appl Physiol 1981;51:485e93.
35. Gunawardena S, Bravo E, Kappagoda CT. Rapidly adapting
receptors in a rabbit model of mitral regurgitation. J Physiol
1999;521(Pt 3):739e48.
36. Bartsch P, Mairbaurl H, Maggiorini M, et al. Physiological
aspects of high-altitude pulmonary edema. J Appl Physiol
2005;98:1101e10.
37. Maggiorini M, Melot C, Pierre S, et al. High-altitude pulmonary
edema is initially caused by an increase in capillary pressure.
Circulation 2001;103:2078e83.
38. Hargreaves M, Ravi K, Kappagoda CT. Responses of slowly and
rapidly adapting receptors in the airways of rabbits to changes
in the Starling forces. J Physiol 1991;432:81e97.
39. Reeves JT, Dempsey JA, Grover RF. Pulmonary circulation
during exercise. In: Weir EK, Reeves JT, editors. Pulmonary
vascular physiology and physiopathology. New York: Marcel
Dekker; 1989. p. 107e33.
40. Matthay MA, Wiener-Kronish JP. Intact epithelial barrier func-
tion is critical for the resolution of alveolar edema in humans.
Am Rev Respir Dis 1990;142:1250e7.
41. Clerici C, Matthay MA. Hypoxia regulates gene expression of
alveolar epithelial transport proteins. J Appl Physiol 2000;88:
1890e6.
42. Mairbaurl H, Mayer K, Kim KJ, et al. Hypoxia decreases active
Na transport across primary rat alveolar epithelial cell
monolayers. Am J Physiol Lung Cell Mol Physiol 2002;282:
L659e65.
43. Mason NP, Petersen M, Melot C, et al. Serial changes in nasal
potential difference and lung electrical impedance tomog-
raphy at high altitude. J Appl Physiol 2003;94:2043e50.
